Posted by Michael Wonder on 14 Nov 2023
Inequitable conduct and invalidation of patents related to FDA regulated products
13 November 2023 - Median brand name drug launch prices increased from $2,115 in 2008 to $180,007 in 2021.
An important factor allowing drug manufacturers to sustain high prices is market exclusivity, length of which is usually defined by drug patents.
